Skip to Main Content

Paper Details

Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.
NPJ Breast Cancer
2
2021
ER+, ER+ve breast cancers, MammaPrint, Patients, hormone, hormone receptor, patient, postmenopausal
Author NameAffiliation
John M S BartlettOntario Institute for Cancer Research
John M S BartlettUniversity of Toronto
John M S BartlettEdinburgh Cancer Research Centre
Jane BayaniOntario Institute for Cancer Research
Elizabeth N KornagaOntario Institute for Cancer Research
Elizabeth N KornagaTom Baker Cancer Centre
Keying XuOntario Institute for Cancer Research
Gregory R PondMcMaster University
Tammy PiperEdinburgh Cancer Research Centre
Elizabeth Mallon
Cindy Q YaoOntario Institute for Cancer Research
Paul C BoutrosOntario Institute for Cancer Research
Paul C BoutrosUniversity of Toronto
Paul C BoutrosUniversity of Toronto
Paul C BoutrosJonsson Comprehensive Cancer Center, University of California los angeles
Annette HasenburgUniversity Center Mainz
Janet A DunnUniversity of Warwick
Christos MarkopoulosNational and Kapodistrian University of Athens
Luc DirixSt. Augustinus Hospital
Caroline SeynaeveErasmus MC Cancer Institute
Cornelis J H van de VeldeLeiden University Medical Center
Robert C SteinNational Institute for Health Research University College London Hospitals Biomedical Research Centre
Daniel ReaCancer Research UK Clinical Trials Unit, University of Birmingham
  • 1 - 23

Datasets